Overview

Schistosoma Haematobium Infections and Praziquantel

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.
Phase:
Phase 3
Details
Lead Sponsor:
University of Khartoum
Collaborator:
Hikma Pharmaceuticals LLC
Treatments:
Praziquantel